Skip to main content
NVDA+1.69%AAPL-0.14%GOOGL+0.91%MSFT-0.43%AMZN-0.30%TSM-0.37%AVGO-1.25%SPCX+4.23%META+0.26%TSLA+0.26%LLY+3.87%BRK-B+1.46%MU+1.50%JPM+0.63%SKHY-1.90%WMT+0.72%AMD-2.86%ASMLa+2.46%V-0.33%XOM+4.41%JNJ+0.99%0700.HK-2.20%MA+0.04%INTC-4.06%CSCO+0.94%BAC+1.09%ABBV+0.76%ORCL+2.73%1398.HK-0.42%AP2d+1.26%COST+0.52%AMAT-3.16%CVX+4.47%CAT-0.55%LRCX-1.59%GE-0.91%KO-0.21%UNH+0.41%HSBA.L+0.35%0005.HK-0.49%HD-1.36%PG+0.45%MS-0.49%NFLX+2.90%BABA+3.04%9988.HK-0.24%0857.HK+1.78%GS-0.49%DELL+0.92%RTX+0.49%GBPJPY+0.96%CADJPY+0.92%USDJPY+0.89%AUDJPY+0.83%NZDJPY+0.77%EURJPY+0.73%CHFJPY+0.55%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%CADCHF+0.29%GBPMXN-0.28%USDCHF+0.27%AUDCHF+0.25%USDTHB+0.21%AUDNOK+0.20%EURGBP-0.19%AUDDKK+0.16%USDILS+0.16%NZDCAD-0.15%GBPNZD+0.15%GBPZAR-0.14%EURCAD-0.14%USDPLN-0.14%NZDCHF+0.14%EURUSD-0.14%EURPLN-0.13%USDMXN-0.13%GBPAUD+0.12%EURCHF+0.12%AUDSGD+0.12%EURAUD-0.10%GBPSGD-0.10%AUDNZD+0.10%NOKJPY-0.10%USDZAR-0.09%EURZAR-0.09%AUDCAD-0.09%NZDUSD-0.09%EURCZK-0.08%USDTRY+0.07%PLNJPY+0.07%GBPUSD+0.06%CHFNOK+0.06%USDSGD-0.05%EURSGD-0.05%NZDMXN-0.05%CHFSEK+0.05%EURNZD-0.05%USDCNH+0.04%USDCOP-0.04%USDCAD-0.04%NZDSGD+0.03%USDNOK+0.03%EURNOK+0.02%SGDJPY-0.02%CHFSGD-0.02%AUDUSD-0.02%USDHKD+0.02%EURHKD+0.02%EURSEK+0.01%EURCNH-0.01%USDDKK-0.01%USDSEK+0.01%GBPCAD+0.01%EURDKK0.00%COFFEE+2.34%XAGUSD-1.22%GAGUSD-1.22%UKOIL-1.16%USOIL-1.11%SUGAR+0.67%XPTUSD-0.32%XNGUSD+0.30%HG1+0.17%XAUUSD+0.12%GAUUSD+0.11%COTTON0.00%BTCUSDT-15.34%BTCUSD+0.53%ETHUSD+0.75%USDTUSD+0.02%BNBUSDT-2.64%XRPUSD-0.03%SOLUSD+0.12%TRXUSDT+1.42%DOGEUSD+0.97%ADAUSDT-24.89%ZECUSDT-0.78%XMRUSDT-0.47%LINKUSD+2.77%XLMUSDT-7.51%XLMUSD+0.06%BCHUSDT-0.79%AVAXUSDT-30.96%SUIUSDT-27.31%LTCUSD+0.77%TONUSD+29.85%TONUSDT+27.64%HBARUSDT-0.63%SUIUSD+0.36%UNIUSD-2.86%TAOUSDT+2.16%UNIUSDT+17.97%NEARUSDT+16.65%AAVEUSD+0.30%DOTUSDT-1.36%ETCUSDT-23.84%ICPUSDT-1.67%PEPEUSD+10041463.34%ONDOUSDT-0.12%WLDUSDT+0.18%ATOMUSDT+2.62%JUPUSDT-0.55%ARBUSDT+0.16%INJUSDT+0.17%PENGUUSDT+101902.18%FETUSDT+0.76%TIAUSDT-0.32%SEIUSDT-0.86%PYTHUSDT-2.34%STXUSDT-0.92%IMXUSDT-1.16%OPUSDT-0.55%AXSUSDT-0.61%GRTUSDT-1.44%NVDA+1.69%AAPL-0.14%GOOGL+0.91%MSFT-0.43%AMZN-0.30%TSM-0.37%AVGO-1.25%SPCX+4.23%META+0.26%TSLA+0.26%LLY+3.87%BRK-B+1.46%MU+1.50%JPM+0.63%SKHY-1.90%WMT+0.72%AMD-2.86%ASMLa+2.46%V-0.33%XOM+4.41%JNJ+0.99%0700.HK-2.20%MA+0.04%INTC-4.06%CSCO+0.94%BAC+1.09%ABBV+0.76%ORCL+2.73%1398.HK-0.42%AP2d+1.26%COST+0.52%AMAT-3.16%CVX+4.47%CAT-0.55%LRCX-1.59%GE-0.91%KO-0.21%UNH+0.41%HSBA.L+0.35%0005.HK-0.49%HD-1.36%PG+0.45%MS-0.49%NFLX+2.90%BABA+3.04%9988.HK-0.24%0857.HK+1.78%GS-0.49%DELL+0.92%RTX+0.49%GBPJPY+0.96%CADJPY+0.92%USDJPY+0.89%AUDJPY+0.83%NZDJPY+0.77%EURJPY+0.73%CHFJPY+0.55%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%CADCHF+0.29%GBPMXN-0.28%USDCHF+0.27%AUDCHF+0.25%USDTHB+0.21%AUDNOK+0.20%EURGBP-0.19%AUDDKK+0.16%USDILS+0.16%NZDCAD-0.15%GBPNZD+0.15%GBPZAR-0.14%EURCAD-0.14%USDPLN-0.14%NZDCHF+0.14%EURUSD-0.14%EURPLN-0.13%USDMXN-0.13%GBPAUD+0.12%EURCHF+0.12%AUDSGD+0.12%EURAUD-0.10%GBPSGD-0.10%AUDNZD+0.10%NOKJPY-0.10%USDZAR-0.09%EURZAR-0.09%AUDCAD-0.09%NZDUSD-0.09%EURCZK-0.08%USDTRY+0.07%PLNJPY+0.07%GBPUSD+0.06%CHFNOK+0.06%USDSGD-0.05%EURSGD-0.05%NZDMXN-0.05%CHFSEK+0.05%EURNZD-0.05%USDCNH+0.04%USDCOP-0.04%USDCAD-0.04%NZDSGD+0.03%USDNOK+0.03%EURNOK+0.02%SGDJPY-0.02%CHFSGD-0.02%AUDUSD-0.02%USDHKD+0.02%EURHKD+0.02%EURSEK+0.01%EURCNH-0.01%USDDKK-0.01%USDSEK+0.01%GBPCAD+0.01%EURDKK0.00%COFFEE+2.34%XAGUSD-1.22%GAGUSD-1.22%UKOIL-1.16%USOIL-1.11%SUGAR+0.67%XPTUSD-0.32%XNGUSD+0.30%HG1+0.17%XAUUSD+0.12%GAUUSD+0.11%COTTON0.00%BTCUSDT-15.34%BTCUSD+0.53%ETHUSD+0.75%USDTUSD+0.02%BNBUSDT-2.64%XRPUSD-0.03%SOLUSD+0.12%TRXUSDT+1.42%DOGEUSD+0.97%ADAUSDT-24.89%ZECUSDT-0.78%XMRUSDT-0.47%LINKUSD+2.77%XLMUSDT-7.51%XLMUSD+0.06%BCHUSDT-0.79%AVAXUSDT-30.96%SUIUSDT-27.31%LTCUSD+0.77%TONUSD+29.85%TONUSDT+27.64%HBARUSDT-0.63%SUIUSD+0.36%UNIUSD-2.86%TAOUSDT+2.16%UNIUSDT+17.97%NEARUSDT+16.65%AAVEUSD+0.30%DOTUSDT-1.36%ETCUSDT-23.84%ICPUSDT-1.67%PEPEUSD+10041463.34%ONDOUSDT-0.12%WLDUSDT+0.18%ATOMUSDT+2.62%JUPUSDT-0.55%ARBUSDT+0.16%INJUSDT+0.17%PENGUUSDT+101902.18%FETUSDT+0.76%TIAUSDT-0.32%SEIUSDT-0.86%PYTHUSDT-2.34%STXUSDT-0.92%IMXUSDT-1.16%OPUSDT-0.55%AXSUSDT-0.61%GRTUSDT-1.44%

VERTEX PHARMACEUTICALS INC (VRTX)

NASDAQ • Healthcare

$523.91
+$27.83 (+5.6%)
Market closed

Last close at August 10, 2026 at 20:00 UTC

Fundamentals Charts

About VERTEX PHARMACEUTICALS INC

Name
VERTEX PHARMACEUTICALS INC
CEO
Reshma Kewalramani
Website
www.vrtx.com
Industry
Healthcare
Year Founded
1989
Employees
6,400

Vertex Pharmaceuticals Incorporated develops and markets prescription medicines in biotechnology, centered on cystic fibrosis treatments and a broader genetic-disease pipeline. The NASDAQ-listed company generated $12.1 billion of revenue in FY2025. Its marketed portfolio includes TRIKAFTA for cystic fibrosis patients with at least one F508del mutation, along with KALYDECO, ORKAMBI, and SYMDEKO/SYMKEVI.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 5 Buy, 1 Hold, 1 Sell
Buy5
Hold1
Sell1

Fundamentals & Financials

Revenue (TTM)
$12.6B
Net Income (TTM)
$4.4B
EPS (TTM)
$17.32
ROA (TTM)
16.06%
Current Ratio
3.19

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ2 FY2026
Revenue$3,333.9M
Cost of Sales$489,200K
Gross Profit$2,844.7M
Operating Income$1,247.3M
Net Income$1,099.8M
EPS$4.33

Technical Indicators

VERTEX PHARMACEUTICALS INC's Technical Indicators Summary

VRTX exhibits bullish positioning as the stock trades above its short-, medium- and long-term averages, while momentum indicators are strong overall with a sizable positive MACD and an extreme CCI reading; RSI is overbought but the broader momentum picture supports the advance. Volume supports the move with a large positive OBV, volatility is moderate and trend strength is modest, and the classic pivot level is well below the current price, reinforcing the support band. Technical takeaway: Buy.

Buy
5 signals
Neutral
1 signal
Sell
1 signal
Overall: Bullish71% Bullish signals
IndicatorValue
RSI (14)
70.19
Stochastic %K (14, 3, 3)
78.33
CCI (20)
430.56
WPR (14)
-27.42
Momentum (10)
44.91
MFI
62.79
MACD Level (12, 26)
5.21
Bollinger Bands
$460.23 - $505.81
ATR (14)
$16.41 (3.13%)
ADX (14)
18.23
OBV
16,958,634
Classic Pivot Point
$491.86
Fibonacci Pivot Point
$491.86
Simple Moving Averages
$455.17 - $487.08(5 indicators)
Exponential Moving Averages
$451.79 - $491.02(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

A steady bid drove VRTX 5.61% higher in the last session, marking a solid advance. Jefferies raises VRTX price target to $633 from $610, maintains Buy rating.

Trading Volume

Above 10d avg 1.5M

2.6M

vs S&P 500 Today

Strong Outperformance

+5.67%

52-Week Position

Upper range

87.1%

Updated: August 11, 2026 at 12:54 UTC

Quote Summary

Previous CloseDay Range$523.91$519.82 - $546.17
52 Week RangeAvg. Volume$374.17 - $546.171.3M
Market CapP/E Ratio$132.9B30.2

Peers & Related Assets

SYKStryker Corporation
$345.81+2.0%
BMYBristol-Myers Squibb Company
$64.84+0.2%
CVSCVS Health Corporation
$95.67-0.0%
MDTMedtronic PLC
$89.41+2.6%
MCKMCKESSON CORP
$879.87+1.2%
HCAHCA HEALTHCARE INC
$414.03+0.2%
REGNRegeneron Pharmaceuticals
$808.05+3.0%
GSKGSK plc
SNYSanofi
ARGXargenx SE